# Gentarget

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gentarget

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Latest round: Series A (Oct 19, 2015)
- Investors on record: 3

## About

Established in 2015 and based in Shenzhen, China, Gentarget is a medicine developer that focuses on the development and clinical application of biological drugs.

The company specializes in the development and clinical translation of viral, non-viral modifications and CRISPR/Cas9 gene editing. It also focuses on the development of First-in-Class biologics to provide drug solutions for multiple major diseases, including malignant tumors, cardiovascular and cerebrovascular diseases, degenerative diseases, and autoimmune diseases.

## Funding rounds

- Series A, Oct 19, 2015 — Green Pine Capital Partners, Tsing-Yuan Capital, Magellan Capital

## Investors

- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Tsing-Yuan Capital (https://capitalatlas.ai/funds/tsing-yuan-capital) — Series A
- Magellan Capital (https://capitalatlas.ai/funds/magellan-capital) — Series A